Ningbo Renjian Pharmaceutical Group Co.
Latest round
- Series A
Last raised
- Sep 2011
Total raised
- Undisclosed
Investors
- 1
About Ningbo Renjian Pharmaceutical Group Co.
, Ltd. develops and produces intermediate biochemical and pharmaceutical products, such as pheromones and urinary estrogen.
Who invested in Ningbo Renjian Pharmaceutical Group Co.
1 investor across 1 round
See all investors in Ningbo Renjian Pharmaceutical Group Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 28, 2011
Amount
Undisclosed
Investors
Questions about Ningbo Renjian Pharmaceutical Group Co.
Who invested in Ningbo Renjian Pharmaceutical Group Co.?
Ningbo Renjian Pharmaceutical Group Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ningbo Renjian Pharmaceutical Group Co. raised?
Ningbo Renjian Pharmaceutical Group Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ningbo Renjian Pharmaceutical Group Co. last raise money?
Ningbo Renjian Pharmaceutical Group Co.'s most recent round on record is a Series A, in Sep 2011.
What does Ningbo Renjian Pharmaceutical Group Co. do?
Ningbo Renjian Pharmaceutical Group Co. is a pharmaceuticals company.
Where is Ningbo Renjian Pharmaceutical Group Co. headquartered?
Ningbo Renjian Pharmaceutical Group Co. is headquartered in Ningbo, China.
Which VCs invest in companies like Ningbo Renjian Pharmaceutical Group Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Ningbo Renjian Pharmaceutical Group Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Ningbo Renjian Pharmaceutical Group Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.